𝔖 Scriptorium
✦   LIBER   ✦

πŸ“

Target Validation in Drug Discovery

✍ Scribed by Brian W. Metcalf, Susan Dillon


Publisher
Academic Press
Year
2006
Tongue
English
Leaves
293
Edition
1
Category
Library

⬇  Acquire This Volume

No coin nor oath required. For personal study only.

✦ Synopsis


This work presents a comprehensive contemporary framework for approaching target validation in drug discovery. It begins with a detailed description of new enabling technologies, including aptamers, RNA interference, functional genomics, and proteomics. The next section looks at biologic drug development with in-depth discussion of lessons learned from such well-known cases as Erbitux, Herceptin, and Avastin. Additional targets known as "second generation" drugs, which can be identified when disease pathways are validated by biologics, present new possible small molecule therapeutics and serve as the focus of the final section of the book.


πŸ“œ SIMILAR VOLUMES


Target Validation in Drug Discovery
✍ Brian W. Metcalf, Susan Dillon πŸ“‚ Library πŸ“… 2006 πŸ› Academic Press 🌐 English

The sequencing of the human genome has offered a genetic description of the entire repertoire of human genes, including a subset of disease targets. Despite this knowledge, now publically available, clinical pipelines are not yet enriched in drugs derived from targets emanating from this massive seq

Target Identification and Validation in
✍ Marta CortΓ©s-Cros, Tobias Schmelzle, Volker M. Stucke, Francesco Hofmann (auth.) πŸ“‚ Library πŸ“… 2013 πŸ› Humana Press 🌐 English

<p><p>The major reason for the elevated costs of drug development in the pharmaceutical industry is the high attrition rate. In <i>Target Identification and Validation in Drug Discovery: Methods and Protocols</i>, expert researchers in the field detail many of the methods which are now commonly used

Target Identification and Validation in
✍ JΓΌrgen Moll, Sebastian Carotta πŸ“‚ Library πŸ“… 2019 πŸ› Springer New York; Humana 🌐 English

<p>This second edition book explores breakthrough technologies in the field of drug target identification and validation. The volume emphasizes particularly revolutionary technologies, such as CRISPR-related screening, β€œbig data,” and <i>in silico</i> approaches, as well as <i>in vivo</i> applicatio

Target Identification and Validation in
✍ Marta CortΓ©s-Cros, Tobias Schmelzle, Volker M. Stucke, Francesco Hofmann (auth.) πŸ“‚ Library πŸ“… 2013 πŸ› Humana Press 🌐 English

<p><p>The major reason for the elevated costs of drug development in the pharmaceutical industry is the high attrition rate. In <i>Target Identification and Validation in Drug Discovery: Methods and Protocols</i>, expert researchers in the field detail many of the methods which are now commonly used